The comparative effects of isoprinosine, levamisole, muramyl dipeptide and SM1213 on lymphocyte and macrophage proliferation and activation in vitro.
D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000494:pharmacology; D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D002455:Cell Division / Q000187:drug effects; D005944:Glucosamine / Q000031:analogs & derivatives* / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D007542:Inosine Pranobex / Q000494:pharmacology; D007978:Levamisole / Q000494:pharmacology; D008089:Listeria monocytogenes; D008213:Lymphocyte Activation / Q000187:drug effects; D008214:Lymphocytes / Q000187:drug effects*; D008264:Macrophages / Q000187:drug effects*; D010587:Phagocytosis / Q000187:drug effects; D010835:Phytohemagglutinins / Q000494:pharmacology; D012266:Ribose / Q000031:analogs & derivatives
D000276:Adjuvants, Immunologic; D010835:Phytohemagglutinins; D007978:Levamisole; D000119:Acetylmuramyl-Alanyl-Isoglutamine; D012266:Ribose; D005944:Glucosamine; C018424:amiprilose; D007542:Inosine Pranobex